Safety Assessment of Antimicrobial Agents: Criteria for the Balance Between Efficacy and Safety (Aventis Pharma/Daiichi Pharmaceutical Co. Ltd./ Ortho-McNeil Pharmaceutical Inc. Joint-Sponsored Symposium At the 22nd International Congress of Chemotherapy)

21 June, 2018
toumei image
Criteria for the Choice of Antimicrobial Agent: Examining the Balance Between Efficacy, Safety, and Tolerability
Hoepelman Professor Andy Hoepelman
Head of Department of Acute Medicine and Infectious Diseases
Professor of Department of Medicine
University Medical Center Utrecht
Utrecht, The Netherlands
toumei image
Clinical Pharmacokinetic/Pharmacodynamic Evidence Regarding the Safety of Levofloxacin
Craig Professor William Craig
Professor of Department of Medicine
University of Wisconsin
Madison, WI, USA
toumei image
Comparison of Safety Profile of Levofloxacin and Other Agents
(-Lactams/-Lactamase Inhibitors, Macrolides, and Other Quinolones )
Garau Professor Javier Garau
Head of Department of Medicine
Hospital Mutua de Terrassa
Associate Professor of Medicine
University of Barcelona
Barcelona, Spain
toumei image
Drug-Drug Interactions with Levofloxacin: Tolerance and Contraindications
Miui Professor Enrico Mini
Associate Professor of Chemotherapy
Department of Preclinical and Clinical Pharmacology
University of Florence
Florence, Italy
toumei image
Levofloxacin Safety Update Focusing on Cardiotoxicity
Ethan Professor Ethan Rubinstein
Professor of Department of Internal Medicine and Unit of Infectious Diseases
Tel Aviv University School of Medicine,
Tel Aviv, Israel
toumei image